(Total Views: 805)
Posted On: 04/04/2023 4:33:13 PM
Post# of 154873
Quote:
10Q coming Monday.
Wonderful. That means we can all look forward to you outlining and emphasizing the company's debt (even though almost all pre-revenue biotechs have significant debt), while simultaneously ignoring any potential value and imminent catalysts.

